Role of galectin‐3 in the pathogenesis and progression of biliary atresia
Dor Yoeli, Cara L. Mack, Nalu Navarro‐Alvarez – 24 November 2022
The Shift from nonalcoholic fatty liver disease to metabolic dysfunction–associated fatty liver disease
Rochelle Wong, Brett E. Fortune – 24 November 2022
The Shift from nonalcoholic fatty liver disease to metabolic dysfunction–associated fatty liver disease
Rochelle Wong, Brett E. Fortune – 24 November 2022
Digital interventions in the management of advanced liver disease: Prescription and monitoring of healthy living in homes
Chansong Choi, Douglas A. Simonetto – 24 November 2022
Treatment of hepatitis C in primary health care in the country of Georgia
Ekaterine Dolmazashvili, Lali Sharvadze, Akaki Abutidze, Nikoloz Chkhartishvili, Manana Todua, Ekaterine Adamia, Tamar Gabunia, Shaun Shadaker, Lia Gvinjilia, Sanjeev Arora, Karla Thornton, Paige A. Armstrong, Tengiz Tsertsvadze – 24 November 2022
Duodenal mucosal resurfacing for nonalcoholic fatty liver disease
Hani Shamseddeen, Raj Vuppalanchi, Mark A. Gromski – 24 November 2022
Falls are an underappreciated driver of morbidity and mortality in cirrhosis
Albert Ha, Zachary M. Saleh, Marina Serper, Elliot B. Tapper – 24 November 2022
Duodenal mucosal resurfacing for nonalcoholic fatty liver disease
Hani Shamseddeen, Raj Vuppalanchi, Mark A. Gromski – 24 November 2022
Role of galectin‐3 in the pathogenesis and progression of biliary atresia
Dor Yoeli, Cara L. Mack, Nalu Navarro‐Alvarez – 24 November 2022